Van beleggers
voor beleggers
desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?

Ontvang nu dagelijks onze kooptips!

word abonnee

Sopheon juni 2018

107 Posts
Pagina: «« 1 2 3 4 5 6 »» | Laatste | Omlaag ↓
  1. [verwijderd] 12 juni 2018 00:15
    kleine correctie: de institutionele beleggers die voor £3M £0.3M+ zijn ingestapt

    ik maakte het wel erg bond; ze hebben nog geen 30% in handen natuurlijk ;-)
    hoeveel ze precies hebben is niet bekend; er is die dag duidelijk meer verhandeld dan wat ze rechtstreeks van het management hebben gekocht; en er is in de weken voorafgaand ook duidelijk meer handel geweest

    maar doet verder allemaal niets af aan mijn verhaal mbt Smithie's opmerkingen
  2. [verwijderd] 12 juni 2018 12:19
    Helemaal gelijk Trinko; ik moet niet meer posten na 0:00u ;-)

    En het moeten er inderdaad meerdere zijn geweest. Denk dat er ook in de maanden vooraf al flink is ingekocht gezien volumes. Wat naar mijn idee ook de lichte terugval nu verklaart; zij hebben de aantallen die ze willen voor dit moment dus er is even wat minder koopdruk. Niets mis mee verder; het kan niet alleen maar stijgen. (hoewel liefst wel natuurlijk)
  3. [verwijderd] 13 juni 2018 18:08
    kijk eens naar Altitude op de aim tikker ALT. Di heeft de potentie van on de pond ook naar 10 pond te gaan binnen enkele jaren is een risicovolle belegging! dus meer een bekijken en is geen beleggings advies.

    Hoort hier misschien niet thuis maar wilde het allen ff onder jullie aandacht brengen.(ben vandaag ingestapt)
    Trinko
  4. marblesthegame 13 juni 2018 18:40
    Issue of Equity
    RNS Number : 3053R
    Sopheon PLC
    13 June 2018

    Issue of Equity



    Sopheon (LSE: SPE), the international provider of software and services for complete Enterprise Innovation Management solutions, announces that, following the exercise of options by an employee, it has issued and allotted 6,069 new ordinary shares of 20 pence each in the Company ("Ordinary Shares"). Application has been made for the new Ordinary Shares to be admitted to trading on AIM and dealings are expected to commence on 20 June 2018.



    The new Ordinary Shares will rank pari passu with the existing shares of the Company. Following the exercise of options, the Company's issued share capital consists of 10,129,957 Ordinary Shares. Accordingly, the figure of 10,129,957 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
  5. [verwijderd] 14 juni 2018 18:49
    Sopheon soars past share price expectations
    Innovation software play has seen its share price increase ten-fold in two and a bit years

    14 June 2018|Big News Issue: 14 Jun 2018 - Page 18
    SOPHEON (SPE:AIM) 880p Gain to date: 167% Original entry point: Buy at 330p, 22 June 2017 It is almost a year since we first flagged the transformation we felt Sopheon (SPE:AIM) was embarking on. The company has a diverse offering, from process automation products to innovation management solutions that help enterprises manage all aspects of their new product development ...

    Gr Trinko
  6. [verwijderd] 21 juni 2018 10:44
    Sopheon the Only Vendor Included in Strategy Execution Management, Portfolio Management & Strategic Roadmapping Research by Leading Analyst Firms

    MINNEAPOLIS – June 20, 2018 – Sopheon, a global leader for enterprise innovation management solutions, was again named in the most recent update to Gartner’s Magic Quadrant for Project Portfolio Management, Worldwide, which offers updated analysis of Project Portfolio Management (PPM) market trends and suppliers.

    A key trend in decision making by executives and portfolio management leaders today is a strong focus on aligning resource investments with strategic value to the organization. It is Sopheon’s belief that this trend strongly validates the unique position of Sopheon and the Accolade software solution in the market.

    Gartner provides guidance on software that aligns with this trend in three separate pieces of research – the Magic Quadrant for Project Portfolio Management, Worldwide, the Market Guide for Strategy Execution Management Software, and the Market Guide for Strategic and Innovation Roadmapping. Sopheon remains the only vendor named in all of these reports. In addition, Sopheon is named as a Leader by Forrester Research, another leading industry analyst firm, in its Forrester Wave™: Strategic Portfolio Management Tools.

    “In our view, this recognition of Sopheon by Gartner and Forrester strongly validates Sopheon’s unique capability to manage the critical enterprise areas of strategic planning, portfolio management, and strategy execution in a single solution,” stated Andy Michuda, Sopheon’s CEO.

    Mr. Michuda continued: “This is a capability we have developed in our Accolade® software in partnership with our customers, who are looking to simplify corporate complexity by reducing the number of disconnected Microsoft® Excel® spreadsheets and other information systems they currently rely on to make fast, informed business decisions.”

    The power of Accolade’s adaptability as a platform has been acknowledged repeatedly by Sopheon’s blue chip customer base, who initially deployed the software to support new product development and have since extended its value to managing strategic planning and execution of corporate funded initiatives, transformational “pivot” change management, cost savings, intellectual property managements, capital expenditures, and others.

    Mr. Michuda added: “The architecture of Sopheon’s Accolade software enables a flexibility and customer-configuration capability, supporting multiple strategic business use cases in ways that are highly searchable, auditable, and easy for users to adopt.”

    Sopheon recommends to prospective software buyers to carefully evaluate prospective software vendors against their specific needs and business use cases, and to take guidance from a broad spectrum of industry research.

    www.sopheon.com/sopheon-strengths-in-...
  7. Paiser 21 juni 2018 12:34
    Door omstandigheden met vertraging,
    Even update over handelen (verkoop) bij rabo, verkoop op limiet werd door beurs na twee dagen geweigerd volgens auto bericht van rabo
    Bestens order werd ook volgens auto bericht geweigerd. Paar uur later tel van Rabo dat ze order handmatig hadden ingegeven en deze was uitgevoerd.
    Vanaf 2004 in Soph, de helft tegen totale aankoopprijs weggedaan.
    In Ned biotech gestopt.
107 Posts
Pagina: «« 1 2 3 4 5 6 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Indices

AEX 875,64 +0,19%
EUR/USD 1,0728 +0,29%
FTSE 100 8.092,38 +0,65%
Germany40^ 17.997,50 -0,50%
Gold spot 2.325,84 +0,42%
NY-Nasdaq Composite 15.712,75 +0,10%

Stijgers

UNILEV...
+5,29%
Flow T...
+4,66%
NX FIL...
+4,01%
Fugro
+1,75%
DSM FI...
+0,96%

Dalers

ADYEN NV
-12,42%
VIVORY...
-6,03%
WDP
-4,38%
IMCD
-2,48%
AZERION
-1,78%

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links